CCCC - C4 Therapeutics, Inc.
IEX Last Trade
4.02
0 0%
Share volume: 24,187
Last Updated: Thu 26 Dec 2024 08:30:13 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.02
0.00
0.00%
Summary score
9%
Profitability
0%
Dept financing
9%
Liquidity
75%
Performance
2%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.75%
Return on assets
-6.83%
Return on sales
-587.54%
Return on invested capital
-67.41%
Total debt ratio
30.72%
Debt ratio change over timeo
-1.82%
Current Ratio
6.99%
Quick Ratio
6.99%
Cash Position Ratio
6.73%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.2%
Return on assets
-7.85%
Return on sales
-639.36%
Return on invested capital
-42.28%
Total debt ratio
35.02%
Debt ratio change over timeo
-1.86%
Current Ratio
5.98%
Quick Ratio
5.98%
Cash Position Ratio
5.66%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-7.17%
Return on assets
-5.63%
Return on sales
-178.59%
Return on invested capital
-34.84%
Total debt ratio
35.17%
Debt ratio change over time
-2.01%
Current Ratio
5.09%
Quick Ratio
5.09%
Cash Position Ratio
4.87%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-75.56%
Return on assets
-82.55%
Return on sales
1186.01%
Return on invested capital
44.92%
Total debt ratio
-181.87%
Debt ratio change over time
-1.82%
Current Ratio
-21.26%
Quick Ratio
-21.26%
Cash Position Ratio
-20.52%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CCCC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.75% | 15.05% | 35.64% | 7.13% |
| Return on assets | -6.83% | 2.88% | 3.13% | 5.53% |
| Return on sales | -587.54% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -67.41% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 30.72% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.82% | 326.95% | -8.44% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 5.98% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 5.98% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 5.66% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 7% | 16% | 39% |
| Short-term ratios | CCCC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.2% | 13.14% | 10.88% | 4.07% |
| Return on assets | -7.85% | 2.1% | 1.54% | 3.03% |
| Return on sales | -639.36% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -42.28% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 35.02% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -1.86% | 51.04% | -101.54% | 1.43% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 5.98% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 5.98% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 5.66% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 9% | 19% | 55% |